- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| BIOHARVEST SCIENCES Aktie jetzt für 0€ handeln | |||||
| Mi | BIOHARVEST SCIENCES INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| Mi | BioHarvest Sciences Inc.: BioHarvest Sciences to Present at Canaccord Genuity 45th Annual Growth Conference on August 12-14, 2025 | 237 | Newsfile | Rehovot, Israel--(Newsfile Corp. - July 23, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 03.07. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | BioHarvest Sciences Inc.: BioHarvest Launches Informed Sport-Certified VINIA DailyChews 2X Formula for Athletes and People with Active Lifestyles | 171 | Newsfile | Rehovot, Israel--(Newsfile Corp. - June 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 21.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.05. | BioHarvest enters fragrance market with new AI-assisted project | 3 | Investing.com | ||
| 21.05. | BioHarvest steigt mit KI-unterstütztem Projekt in den Duftmarkt ein | 2 | Investing.com Deutsch | ||
| 21.05. | BioHarvest secures new CDMO contract to develop plant-based fragrance compound | 3 | Seeking Alpha | ||
| 21.05. | BioHarvest Sciences Inc.: BioHarvest Secures New CDMO Contract to Develop Plant-based Fragrance Compound | 311 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 21, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 16.05. | BioHarvest outlines path to $11M-$12M quarterly revenue for adjusted EBITDA breakeven while expanding VINIA portfolio and CDMO pipeline | 2 | Seeking Alpha | ||
| 15.05. | BioHarvest Sciences Inc.: BioHarvest Sciences Reports First Quarter 2025 Financial Results | 330 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 15, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 12.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 12.05. | BioHarvest Sciences Inc.: BioHarvest Announces Completion of Stage 1 Development for CDMO Contract with Nasdaq-Listed Pharmaceutical Company | 264 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 05.05. | BioHarvest stock gains on new Buy rating, $15 target from Craig-Hallum | 4 | Investing.com | ||
| 01.05. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 01.05. | BioHarvest Sciences Inc.: BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time | 244 | Newsfile | Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology... ► Artikel lesen | |
| 08.04. | H.C. Wainwright maintains BioHarvest stock Buy rating, $14 target | 1 | Investing.com | ||
| 01.04. | BIOHARVEST SCIENCES INC. - 6-K, Report of foreign issuer | 1 | SEC Filings |
1 2 3 Weiter >>
56 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 29,125 | +2,28 % | Zäsur im deutschen Gesundheitswesen! Wagen wir bald mehr USA? PanGenomic Health, Bayer, Nestlé | Gibt es US-amerikanische Verhältnisse bald auch in Deutschland? Gesundheitsökonom Jürgen Wasem fordert mehr Selbstbeteiligung von Patienten. Bestimmte Medikamente könnten von der Verschreibungspflicht... ► Artikel lesen | |
| PFIZER | 21,595 | +0,12 % | Pfizer Completes Licensing Agreement With 3SBio For Cancer Drug | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) Thursday said it has completed the licensing agreement with 3SBio, Inc. for exclusive rights to develop and sell 3SBio's SSGJ-707.As per the deal... ► Artikel lesen | |
| MERCK KGAA | 113,35 | +0,94 % | Aktie von Merck an der Börse auf der Verliererseite: Börsenkurs fällt deutlich (106,70 €) | Die Aktie von Merck zählt am Dienstag zu den großen Verlierern an der Börse. Der Kurs des Wertpapiers sackt kräftig ab. Die Merck-Aktie gehört heute mit einem Minus von 3,18 Prozent zu den Werten mit... ► Artikel lesen | |
| AURORA CANNABIS | 4,055 | -0,49 % | AURORA CANNABIS INC - 6-K, Report of foreign issuer | ||
| CANOPY GROWTH | 0,977 | +0,83 % | Canopy Growth Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 0,610 | +1,67 % | Tilray Brands, Inc.: Award-Winning Breckenridge Distillery Makes Bold Entry into Tequila with Launch of Casa Breck | ||
| BRISTOL-MYERS SQUIBB | 41,800 | +0,31 % | Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock? | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| DERMAPHARM | 35,300 | +2,17 % | Dermapharm: Viele Pläne für 2025 | Dermapharm wird 0,90 Euro je Aktie als Dividende an die Aktionäre überweisen. Das erfüllt die Erwartungen der Analysten von mwb research. Dies entspricht einer Ausschüttungsquote von 43 Prozent. Insgesamt... ► Artikel lesen | |
| CRONOS GROUP | 1,742 | -0,80 % | High Tide schließt mit Cronos Group Inc. eine Vereinbarung über Wandelschuldverschreibungen im Wert von 30 Millionen $ ab | CALGARY, AB, und TORONTO, ON, 16. Juli 2025 / IRW-Press / High Tide Inc. ("High Tide" oder das "Unternehmen") (Nasdaq: HITI) (TSXV: HITI) (FWB: 2LYA), das
erfolgreiche, auf den Einzelhandel fokussierte... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 9,258 | +3,86 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
| INCYTE | 60,06 | +0,17 % | Incyte To Present Initial Data for its TGFßR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (ESMO) Congress 2025 | Mini oral presentation to highlight initial Phase 1 data of INCA33890, a promising TGFßR2×PD-1-directed bispecific antibody, in patients with advanced or metastatic solid tumors
Oral presentation... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,350 | +4,65 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 02.04.2025 | The following instruments on XETRA do have their first trading 02.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 02.04.2025
Aktien
1 ROMEDLACNOR6 MedLife S.A.
2 CA29872T2092... ► Artikel lesen |
BIOHARVEST SCIENCES INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 6,100 Euro und damit +5,17 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIOHARVEST SCIENCES INC finden Sie auf Wallstreet Online.